13F filer · CIK 1602263
VHCP Management II, LLC
New York, NY · filing since Q4 2015 · last filing Feb 13, 2020
Reported value
$379.4M
+$116.9M vs prior
Positions
20
New / sold out
8 / 9
Added / reduced
1 / 7
Turnover
20.8%
buys $66.6M · sells $107.3M
Top-10 weight
94.1%
Biggest buys vs Q3 2019
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | Constellation Pharmaceuticals | +773,954 | +106.5% | +$36.5M |
| New | Iveric Bio Inc | +1,004,299 | – | +$8.6M |
| New | Mersana Therapeutics Inc | +922,514 | – | +$5.3M |
| New | Relmada Therapeutics Inc | +114,876 | – | +$4.5M |
| New | Adverum Biotechnologies Inc | +383,620 | – | +$4.4M |
| New | Forty Seven Inc | +77,714 | – | +$3.1M |
| New | Nextcure Inc | +36,249 | – | +$2.0M |
| New | Myovant Sciences Ltd | +76,768 | – | +$1.2M |
| New | 89Bio Inc | +41,235 | – | +$1.1M |
Biggest sells vs Q3 2019
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | Ascendis Pharma A/S | -234,591 | -100.0% | $-22.6M |
| Sold out | Ra Pharmaceuticals | -677,164 | -100.0% | $-16.0M |
| Reduced | Shockwave Medical Inc | -357,589 | -55.3% | $-15.7M |
| Reduced | Biohaven Pharmaceuticals | -250,000 | -35.1% | $-13.6M |
| Reduced | Axsome Therapeutics Inc | -106,965 | -12.0% | $-11.1M |
| Sold out | BioCryst Pharmaceuticals Inc | -2,874,602 | -100.0% | $-8.2M |
| Sold out | Kiniksa Pharmaceuticals Ltd | -540,461 | -100.0% | $-4.6M |
| Sold out | La Jolla Pharmaceuticals | -518,102 | -100.0% | $-4.6M |
| Sold out | Tricida Inc | -118,886 | -100.0% | $-3.7M |
| Reduced | Protagonist Therapeutics Inc | -394,570 | -92.5% | $-2.8M |
6 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q4 2019
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | 10X Genomics Inc.COM | 1,786,431 | $136.2M | 35.91% |
| 2 | Axsome Therapeutics IncCOM | 785,981 | $81.2M | 21.42% |
| 3 | Constellation PharmaceuticalsCOM | 1,500,631 | $70.7M | 18.64% |
| 4 | Biohaven PharmaceuticalsCOM | 462,903 | $25.2M | 6.64% |
| 5 | Shockwave Medical IncCOM | 288,838 | $12.7M | 3.34% |
| 6 | Iveric Bio IncCOM | 1,004,299 | $8.6M | 2.27% |
| 7 | Kalvista PharmaceuticalsCOM | 366,268 | $6.5M | 1.72% |
| 8 | Obseva SACOM | 1,573,639 | $6.0M | 1.58% |
| 9 | Mersana Therapeutics IncCOM | 922,514 | $5.3M | 1.39% |
| 10 | Spero Therapeutics IncCOM | 474,015 | $4.6M | 1.20% |
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.